Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide is a synthetic small molecule belonging to the benzimidazole class of organic compounds. It has a molecular formula of C17H13N5O and a molecular weight of approximately 303.32 g/mol[1][2][3][4]. The compound is experimental and not approved for clinical use in any country[2]. Its mechanism of action is not well characterized; however, it has been associated with potential ATP binding activity and may interact with cyclin-dependent kinase 2 (CDK2), suggesting possible utility as a kinase inhibitor in research settings[2]. There are no known clinical indications or ongoing clinical trials for this compound.
- Other names
- N-(3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl)benzamideBenzamide, N-(3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl)-
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide.